Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biosimilars Players Climb Global Rankings
Final Part Of Top 50 Ranking Sees Biosimilars Specialists Making Progress
Aug 11 2021
•
By
David Wallace
Biosimilars players are rising up the rankings amid small-molecule generic peers • Source: Alamy/Informa
More from Company Rankings
More from Market Intelligence